ArticleMolecular pharmaceutics2015
Preclinical studies of the potent and selective nicotinic α4β2 receptor ligand VMY-2-95.
Hyesik Kong et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it
ArticleMolecular pharmaceutics2015
Hyesik Kong et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.